Chemist + Druggist is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Be ready for EU scanning law 6 months early, warns Alliance

Contractors must brace themselves for EU anti-counterfeiting legislation six months before it comes into effect, Alliance Healthcare’s managing director has warned.

When the falsified medicines directive (FMD) comes into force in February 2019, it will require every pharmacy in the UK to scan barcodes, check tamper-proof devices and decommission medicines to prevent them from being reused. 

In an exclusive interview with C+D last week (August 31), Alliance Healthcare managing director Jeremy Main said pharmacies should be prepared for the EU law by September 2018, so they are not caught off-guard by the Christmas and New Year rush.

The sector can no longer afford to “bury its head in the sand” about the legislation, as it will have a “big impact” on community pharmacy, Mr Main said.

Two-year timeframe

“FMD is one of the big challenges we’ve got ahead,” he added. “It’s got to be implemented by February 2019, but we’ll really need to have done the work by September 2018, which is just two years away.”

Alliance Healthcare estimates that gearing up for the implementation of the legislation could cost millions, through buying new equipment – such as barcode scanners to track and trace medicines – and introducing new working practices for staff.

 “We think we now fully understand what needs to be done, and we’re going to make sure that we implement the right solution to support our business and the whole industry,” Mr Main said.

Hub-and-spoke concerns

Mr Main also said plans to introduce more automation in the sector – by allowing independent pharmacies to legally operate automated dispensing hubs – appeared to be “in the long grass” for now.

While Alliance Healthcare has gained some experience of operating central dispensing hubs from Boots – also owned by parent company Walgreen Boots Alliance – Mr Main said he still has concerns that hub-and-spoke is “not yet proven”.

Find out what Mr Main's two "biggest concerns" are with the hub-and-spoke model here.

How are you preparing for the EU scanning law?

Related Content


Pharmacy Dispenser/ Technician
Bethnal Green North, London
Salary: Up to £30,000

Apply Now



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts